Answer
Rifampin, a CYP3A4 inducer, may decrease plasma concentrations of pazopanib hydrochloride; an alternative concomitant medicine with no or minimal enzyme or transporter induction potential is recommended.
Sources for this answer
- Votrient 200 mg and 400 mg film coated tabletsNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.5 Interaction with other medicinal products · Version 36Document updated
Sources checked